Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
lucitanib (E 3810)
i
Other names:
E 3810, E-3810, S 80881, AL 3810, CO-3810, S-80881, S-80881-2, AL3810
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Clovis, HaiHe Biopharma, Servier
Drug class:
FGFR inhibitor, VEGFR inhibitor, Tyrosine kinase inhibitor, PDGFR α-β inhibitor
Related drugs:
‹
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
sunitinib (139)
axitinib (34)
fruquintinib (24)
cediranib (9)
surufatinib (7)
MGCD265 (4)
OMP-305B83 (3)
ABT-869 (2)
DC101 (1)
vorolanib (1)
CS 2164 (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
IMC-18F1 (0)
ABT348 (0)
SU5416 (0)
GS 6624 (0)
BAY 57- 9352 (0)
RG7221 (0)
PTK787 (0)
PD173074 (10)
BBT-176 (5)
befotertinib (3)
CLN-081 (2)
AG-1296 (1)
KC1036 (1)
rilertinib (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
XL092 (0)
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
WXSH0011 (5)
ICP-192 (5)
CPL304110 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
sunitinib (139)
axitinib (34)
fruquintinib (24)
cediranib (9)
surufatinib (7)
MGCD265 (4)
OMP-305B83 (3)
ABT-869 (2)
DC101 (1)
vorolanib (1)
CS 2164 (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
IMC-18F1 (0)
ABT348 (0)
SU5416 (0)
GS 6624 (0)
BAY 57- 9352 (0)
RG7221 (0)
PTK787 (0)
PD173074 (10)
BBT-176 (5)
befotertinib (3)
CLN-081 (2)
AG-1296 (1)
KC1036 (1)
rilertinib (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
XL092 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR1 overexpression + HR positive
HER2 Negative Breast Cancer
FGFR1 overexpression + HR positive
HER2 Negative Breast Cancer
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
FGF amplification
Breast Cancer
FGF amplification
Breast Cancer
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
FGFR1 amplification + HR positive
HER2 Negative Breast Cancer
FGFR1 amplification + HR positive
HER2 Negative Breast Cancer
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
E 3810
Sensitive: C3 – Early Trials
E 3810
Sensitive
:
C3
PALB2 mutation
Endometrial Cancer
PALB2 mutation
Endometrial Cancer
rucaparib + E 3810
Sensitive: C4 – Case Studies
rucaparib + E 3810
Sensitive
:
C4
rucaparib + E 3810
Sensitive: C4 – Case Studies
rucaparib + E 3810
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login